Ohtsu A - Search Results

1

Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trials.

Nagatani Y, Shitara K, Bando H, Kuboki Y, Okamoto W, Kojima T, Yoshino T, Nishida T, Ohtsu A, Doi T. Nagatani Y, et al. Among authors: ohtsu a. BMC Cancer. 2016 Nov 14;16(1):889. doi: 10.1186/s12885-016-2939-0. BMC Cancer. 2016. PMID: 27842521 Free PMC article.

2

Clinical features of interstitial lung disease induced by standard chemotherapy (FOLFOX or FOLFIRI) for colorectal cancer.

Shimura T, Fuse N, Yoshino T, Minashi K, Tahara M, Doi T, Joh T, Ohtsu A. Shimura T, et al. Among authors: ohtsu a. Ann Oncol. 2010 Oct;21(10):2005-2010. doi: 10.1093/annonc/mdq061. Epub 2010 Mar 19. Ann Oncol. 2010. PMID: 20305036 Free article.

3

Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors.

Doi T, Murakami H, Ohtsu A, Fuse N, Yoshino T, Yamamoto N, Boku N, Onozawa Y, Hsu CP, Gorski KS, Friberg G, Kawaguchi T, Sasaki T. Doi T, et al. Among authors: ohtsu a. Cancer Chemother Pharmacol. 2011 Sep;68(3):733-41. doi: 10.1007/s00280-010-1544-1. Epub 2010 Dec 16. Cancer Chemother Pharmacol. 2011. PMID: 21161528 Clinical Trial.

4

KRAS mutations detected by the amplification refractory mutation system-Scorpion assays strongly correlate with therapeutic effect of cetuximab.

Bando H, Yoshino T, Tsuchihara K, Ogasawara N, Fuse N, Kojima T, Tahara M, Kojima M, Kaneko K, Doi T, Ochiai A, Esumi H, Ohtsu A. Bando H, et al. Among authors: ohtsu a. Br J Cancer. 2011 Jul 26;105(3):403-6. doi: 10.1038/bjc.2011.247. Epub 2011 Jul 5. Br J Cancer. 2011. PMID: 21730978 Free PMC article.

5

KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer.

Kawamoto Y, Tsuchihara K, Yoshino T, Ogasawara N, Kojima M, Takahashi M, Ochiai A, Bando H, Fuse N, Tahara M, Doi T, Esumi H, Komatsu Y, Ohtsu A. Kawamoto Y, et al. Among authors: ohtsu a. Br J Cancer. 2012 Jul 10;107(2):340-4. doi: 10.1038/bjc.2012.218. Epub 2012 May 22. Br J Cancer. 2012. PMID: 22617127 Free PMC article.

6

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours.

Doi T, Ohtsu A, Yoshino T, Boku N, Onozawa Y, Fukutomi A, Hironaka S, Koizumi W, Sasaki T. Doi T, et al. Among authors: ohtsu a. Br J Cancer. 2012 Jul 24;107(3):429-34. doi: 10.1038/bjc.2012.274. Epub 2012 Jun 26. Br J Cancer. 2012. PMID: 22735906 Free PMC article. Clinical Trial.

7

Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial).

Yoshida M, Muro K, Tsuji A, Hamamoto Y, Yoshino T, Yoshida K, Shirao K, Miyata Y, Takahari D, Takahashi T, Ohtsu A. Yoshida M, et al. Among authors: ohtsu a. Eur J Cancer. 2015 May;51(8):935-41. doi: 10.1016/j.ejca.2015.03.007. Epub 2015 Mar 30. Eur J Cancer. 2015. PMID: 25837882 Free article. Clinical Trial.

8

Phase I trial of combination chemotherapy with docetaxel, cisplatin and S-1 (TPS) in patients with locally advanced or recurrent/metastatic head and neck cancer.

Tahara M, Araki K, Okano S, Kiyota N, Fuse N, Minashi K, Yoshino T, Doi T, Zenda S, Kawashima M, Ogino T, Hayashi R, Minami H, Ohtsu A. Tahara M, et al. Among authors: ohtsu a. Ann Oncol. 2011 Jan;22(1):175-180. doi: 10.1093/annonc/mdq298. Epub 2010 Jun 7. Ann Oncol. 2011. PMID: 20530200 Free article. Clinical Trial.

9

Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients.

Doi T, Takiuchi H, Ohtsu A, Fuse N, Goto M, Yoshida M, Dote N, Kuze Y, Jinno F, Fujimoto M, Takubo T, Nakayama N, Tsutsumi R. Doi T, et al. Among authors: ohtsu a. Br J Cancer. 2012 Feb 14;106(4):666-72. doi: 10.1038/bjc.2011.590. Epub 2012 Jan 12. Br J Cancer. 2012. PMID: 22240796 Free PMC article. Clinical Trial.

10

Phase I trial of pimasertib monotherapy in Japanese patients with solid tumors and those with hepatocellular carcinoma.

Yamazaki K, Doi T, Ikeda M, Okusaka T, Schueler A, Watanabe M, Ohtsu A. Yamazaki K, et al. Among authors: ohtsu a. Cancer Chemother Pharmacol. 2019 Nov;84(5):1027-1037. doi: 10.1007/s00280-019-03924-0. Epub 2019 Sep 3. Cancer Chemother Pharmacol. 2019. PMID: 31482223 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters